It takes a village
What does it take to bring the ACAAI Annual Scientific Meeting to life each year? Believe it or not, planning takes years to prepare.
2024 Cyberattacks cause disruptions
Due to the attack, Change Healthcare's systems are still down, causing struggles for physician practices and hospitals filing claims, as well as for pharmacies…
AllergyTalk: Two Special Podcasts: Omalizumab for Food Allergy
On February 16, 2024, the FDA announced the approval of the first biologic medication to treat patients with food allergy, omalizumab
Clinical Trial Resources provide an important link to medical research
Learn about opportunities that may help your patients either now or in the future.
Addressing Cannabis use with patients
A survey revealed 75% of surveyed allergists were only somewhat knowledgeable about respiratory effects and allergic reactions to cannabis
Coding for E&M visit and allergy testing on the same day
Many third-party payers insist skin tests are a part of an office visit, but this is not the case, and these denials should be appealed.
Impact of 340B Drug Discount Program
While 340B is not the most relevant federal program for allergy practices, it is helpful to have a better understanding of how it works.
2024 Call for State Delegates and Regional Super Delegates
There is still time to be a part of the College’s House of Delegates! We’re looking for State and Super Delegates. Are you ready to join us?